Skip to main content
. 2011 Nov 1;26(1):20–27. doi: 10.1007/s00540-011-1261-x

Table 2.

Demographic and system organ class of patients in a study testing the safety and efficacy of oral rehydration therapy until 2 h before surgery

ORS group Fasting group P
Sex, men/women 36/99 39/100 NSa
Age, mean (SD) (years) 47.9 (13.5) 48.6 (14.9) NSb
Body mass index, mean (SD) (kg m−2) 22.5 (3.1) 23.1 (4.0) 0.14b
ASA physical status (n) NSa
 I 88 91
 II 47 48
System organ class (n) NSa
 Neoplasms benign, malignant, and unspecified 90 91
 Infections and infestations 14 11
 Musculoskeletal and connective tissue disorders 10 13
 Reproductive system and breast disorders 6 4
 Injury, poisoning, and procedural complications 4 8
 Surgical and medical procedures 3 5
 Respiratory, thoracic, and mediastinal disorders 2 4
 Endocrine disorders 2 2
 Gastrointestinal disorders 2 0
 Nervous system disorders 1 1
 Skin and subcutaneous tissue disorders 1 0
Duration of surgery, mean (SD) (min) 155.3 (113.0) 152.5 (99.9) NSb
Duration of anesthesia, mean (SD) (min) 213.7 (120.2) 212.1 (105.2) NSb
Intraoperative blood loss, mean (SD) (ml) 366.8 (751.0) 295.8 (379.3) NSb

ASA American Society of Anesthesiologists, ORS oral rehydration solution

aChi-square test, α = 0.15

bUnpaired t test, α = 0.15